50 results match your criteria: "MedStar Heart Institute[Affiliation]"
Circ Cardiovasc Qual Outcomes
October 2023
Cleveland Clinic Florida, Weston (D.S.).
J Health Econ Outcomes Res
January 2018
Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA.
Pulmonary arterial hypertension (PAH) is described by proliferation of small pulmonary arteries leading to increased pulmonary vascular resistance, right ventricular failure, and death. Research confirms long-term improvement in composite morbidity and mortality endpoints on some endothelin receptor antagonists alone and in combination with phosphodiesterase type 5 inhibitors (PDE-5is) but not with PDE-5i monotherapy. While current treatment guidelines incorporate these findings, a substantial number of patients are started or maintained on PDE-5i monotherapy.
View Article and Find Full Text PDFN Engl J Med
February 2017
From Duke University School of Medicine, Durham, NC (J.G.R., C.A.M.); University of Michigan, Ann Arbor (F.D.P., K.D.A.); Advocate Christ Medical Center, Oak Lawn (A.J.T., G.B.), and University of Chicago Medicine (V.J.) and Northwestern Memorial Hospital (A.S.A.), Chicago - all in Illinois; University of Louisville, Louisville, KY (M.S.S., E.J.B.); MedStar Heart Institute, Washington, DC (S.W.B., S.S.N.); University of Texas Health Science Center (I.D.G.) and Texas Heart Institute (H.M., O.H.F.), Houston; and HeartWare, Framingham, MA (K.L.).
Background: Mechanical circulatory support with a left ventricular assist device (LVAD) is an established treatment for patients with advanced heart failure. We compared a newer LVAD design (a small intrapericardial centrifugal-flow device) against existing technology (a commercially available axial-flow device) in patients with advanced heart failure who were ineligible for heart transplantation.
Methods: We conducted a multicenter randomized trial involving 446 patients who were assigned, in a 2:1 ratio, to the study (centrifugal-flow) device or the control (axial-flow) device.
J Clin Oncol
March 2017
Saro H. Armenian, City of Hope, Duarte, CA; Christina Lacchetti, American Society of Clinical Oncology, Alexandria; Neelima Denduluri, Virginia Cancer Specialists, Arlington, VA; Ana Barac, Medstar Heart Institute, Medstar Washington Hospital Center, Washington, DC; Joseph Carver and Mariell Jessup, University of Pennsylvania; Bonnie Ky, Hospital of the University of Pennsylvania, Philadelphia, PA; Louis S. Constine, University of Rochester Medical Center, Rochester; Lee W. Jones and Kevin Oeffinger, Memorial Sloan Kettering Cancer Center, New York, NY; Susan Dent, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada; Pamela S. Douglas, Duke University, Durham, NC; Jean-Bernard Durand and Michael Ewer, The University of Texas MD Anderson Cancer Center, Houston, TX; Carol Fabian, University of Kansas Medical Center, Kansas City, KS; Melissa Hudson, St Jude Children's Research Hospital, Memphis; Javid Moslehi and Daniel Lenihan, Vanderbilt University; Katharine Ray, Patient Representative, Nashville, TN; Erica L. Mayer, Dana-Farber Cancer Institute, Boston, MA; and Kathryn Ruddy, Mayo Clinic, Rochester, MN.
Purpose Cardiac dysfunction is a serious adverse effect of certain cancer-directed therapies that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual survival of the patient with cancer. The purpose of this effort was to develop recommendations for prevention and monitoring of cardiac dysfunction in survivors of adult-onset cancers. Methods Recommendations were developed by an expert panel with multidisciplinary representation using a systematic review (1996 to 2016) of meta-analyses, randomized clinical trials, observational studies, and clinical experience.
View Article and Find Full Text PDFJ Am Coll Cardiol
June 2016
Department of Cardiology, Heart Center Bonn, University Hospital Bonn, Bonn, Germany.
Background: Current surgical and medical treatment options for functional mitral regurgitation (FMR) are limited and additional interventional approaches are required.
Objectives: This study sought to report the safety and performance data from the feasibility study with a novel direct annuloplasty system.
Methods: Seventy-one patients with moderate to severe FMR (mean 67.
ASAIO J
December 2017
From the *Division of Cardiovascular Medicine, Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan; †Department of Thoracic and Cardiovascular Surgery, Florida Hospital, Orlando, Florida; ‡Department of Cardiac Surgery, Mayo Clinic Rochester, Rochester, Minnesota; §Heart and Lung Transplant Center, Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, Texas; ¶Departments of Internal Medicine and Cardiac Surgery, MedStar Heart Institute, Washington, DC; ‖HeartWare Inc., Framingham, Massachusetts; and #Division of Cardiothoracic Surgery, University of Louisville, Louisville, Kentucky.
Advanced heart failure patients who are classified as bridge to transplant (BTT) often remain on mechanical circulatory support (MCS) for long durations because of the limited supply of donor organs. Here, we present the outcomes of patients who have been supported by the HeartWare ventricular assist device system for more than 2 years. In the HeartWare BTT and continued access protocol trial, 74 of the 382 total patients (19.
View Article and Find Full Text PDFAm J Cardiol
January 2016
Department of Cardiology, MedStar Heart & Vascular Institute, Medstar Heart Institute, Washington, DC.
This analysis was designed to (1) examine the impact of heparin-induced thrombocytopenia (HIT) on contemporary cardiac surgical practice and (2) describe the results of a protocol designed for early identification of the presence of the immune mechanisms involved. Consecutive patients who underwent cardiac surgery were screened postoperatively for thrombocytopenia. Patients with thrombocytopenia were tested for antiplatelet factor 4 (PF4)/heparin antibodies by ELISA and clinical evidence of thrombosis sought.
View Article and Find Full Text PDFAm J Cardiol
January 2016
Division of Cardiology, Department of Medicine, MedStar Georgetown University Hospital, MedStar Heart Institute, Washington, DC. Electronic address:
Echocardiography is the preferred initial imaging method for assessment of cardiac masses. Cardiac magnetic resonance (CMR) imaging, with its excellent tissue characterization and wide field of view, may provide additional unique information. We evaluated the predictive value of echocardiography and CMR imaging parameters to identify tumors and malignancy and to provide histopathologic diagnosis of cardiac masses.
View Article and Find Full Text PDFJ Cardiovasc Comput Tomogr
September 2016
Advanced Cardiac Imaging, King Abdulaziz Cardiac Center, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.
Practice guidelines issued by professional societies significantly impact cardiology practice throughout the world. They increasingly incorporate cardiac CT imaging. This review systematically analyzes clinical practice guidelines issued by the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) and the European Society of Cardiology (ESC) as well as the multi-societal appropriateness criteria in their latest versions as of September 1st, 2015, in order to identify the extent to which they include recommendations to use cardiac CT in specific clinical situations.
View Article and Find Full Text PDFAnn Thorac Surg
August 2015
Division of Cardiothoracic Surgery, Institute of Human Values in Health Care, Medical University of South Carolina, Charleston, South Carolina. Electronic address:
Am J Manag Care
June 2015
Medstar Heart Institute, 110 Irving St NW, Washington, DC 20010. E-mail:
Pulmonary arterial hypertension (PAH) is a rare, progressive, and potentially fatal cardiopulmonary syndrome that imposes a significant burden on patients in terms of morbidity and mortality, and on managed care organizations in terms of resource utilization. The majority of PAH-approved therapies are high-touch, high-management, high-cost treatments dispensed through specialty pharmacies. Current treatment guidelines recommend combination therapy for patients who show inadequate clinical response or who deteriorate on monotherapy.
View Article and Find Full Text PDFJ Grad Med Educ
December 2014
Director of Research, Advanced Heart Failure Program, MedStar Heart Institute, MedStar Washington Hospital Center.
Am J Cardiol
March 2015
Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address:
Both hyperkalemia and hypokalemia may be related to heart failure (HF) therapy and are associated with adverse outcomes. Abnormalities in serum potassium levels in hospitalized patients with HF and reduced ejection fraction (EF) have not been previously investigated. A post hoc analysis was performed in 1,907 hospitalized patients with worsening HF and reduced EF in the placebo arm of the Efficacy of Vasopressin Antagonism in HF Outcome Study with Tolvaptan (EVEREST) trial.
View Article and Find Full Text PDFJ Am Soc Echocardiogr
February 2015
AZ St Jan Brugge, Brugge, Belgium.
Pulm Circ
December 2014
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA ; Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
Patients with early repair of an isolated atrial septal defect (ASD) are expected to have unremarkable right ventricular (RV) and pulmonary circulation physiology. Some studies, however, suggest persistent functional impairment. We aimed to examine the role of abnormal RV and pulmonary vascular response to exercise in patients who had undergone ASD closure.
View Article and Find Full Text PDFAm Heart J
January 2015
MedStar Cardiovascular Research Network, MedStar Heart Institute, Medstar Washington Hospital Center, Washington, DC. Electronic address:
Background: Multiple studies have evaluated the diagnostic and prognostic performance of conventional troponin (cTn) and high-sensitivity troponin (hs-cTn). We performed a collaborative meta-analysis comparing cTn and hs-cTn for diagnosis of acute myocardial infarction (AMI) and assessment of prognosis in patients with chest pain.
Methods: MEDLINE/PubMed, Cochrane CENTRAL, and EMBASE were searched for studies assessing both cTn and hs-cTn in patients with chest pain.
Cardiovasc Revasc Med
March 2016
MedStar Cardiovascular Research Network, MedStar Heart Institute, Medstar Washington Hospital Center, Washington, DC, USA. Electronic address:
Aims: Given controversy over anticoagulation regimens for percutaneous coronary intervention (PCI), we performed an updated meta-analysis of randomized controlled trials (RCTs) to compare bivalirudin versus heparin.
Methods And Results: Medline/Pubmed and Cochrane CENTRAL were searched for all RCTs comparing bivalirudin with provisional glycoprotein IIb/IIIa inhibitor (GPI) use versus heparin with provisional or routine GPI use for PCI. Pooled estimates of 30day outcomes, presented as risk ratios (RR) [95% confidence intervals], were generated with random-effect models.
Catheter Cardiovasc Interv
November 2014
Division of Cardiology, MedStar Heart Institute, MedStar Washington Hospital Center, Washington, District of Columbia.
J Cardiovasc Transl Res
November 2014
MedStar Cardiovascular Research Network, MedStar Heart Institute, Washington Hospital Center, 108 Irving Street, NW Room 214, Washington, DC, 20010, USA.
Chronic stress is associated with increased risk of cardiovascular diseases. Aging is also associated with vascular dysfunction. We hypothesize that chronic stress accelerates collateral dysfunction in old mice.
View Article and Find Full Text PDFHypertension
December 2014
From the Hospital San Raffaele Pisana-Istituto Ricovero e Cura a Carattere Sceintifico (IRCCS), Rome, Italy (A.S.); Laboratory of Cardiovascular Science, National Institute of Aging, Baltimore, MD (C.H.M., J.B.S., K.V.T., H.S., E.G.L.); Loyola University Maryland, Baltimore (C.H.M.); Istituto di Ricerca Genetica e Biomedica (IRGB), Consiglio Nazionale delle Ricerche, c/o Cittadella Universitaria di Monserrato, Monserrato, Cagliari, Italy (M.O., L.A.P.F., F.L., M.G.P., A.D.); Johns Hopkins School of Medicine, Baltimore, MD (M.A.); and MedStar Heart Institute, Washington, DC (S.S.N.).
The age-associated increase in arterial stiffness has long been considered to parallel or to cause the age-associated increase in blood pressure (BP). Yet, the rates at which pulse wave velocity (PWV), a measure of arterial stiffness, and BP trajectories change over time within individuals who differ by age and sex have not been assessed and compared. This study determined the evolution of BP and aortic PWV trajectories during a 9.
View Article and Find Full Text PDFJ Am Coll Cardiol
September 2014
MedStar Cardiovascular Research Network, MedStar Heart Institute, MedStar Washington Hospital Center, Washington, DC.
J Cardiovasc Comput Tomogr
May 2015
Cardiology Division, MedStar Heart Institute, MedStar Washington Hospital Center, 110 Irving Street, NW, Washington DC 20010, USA.
Cardiac CT, specifically coronary CT angiography (CTA), is an established technology which detects anatomically significant coronary artery disease with a high sensitivity and negative predictive value compared with invasive coronary angiography. However, the limited ability of CTA to determine the physiologic significance of intermediate coronary stenoses remains a shortcoming compared with other noninvasive methods such as single-photon emission CT, stress echocardiography, and stress cardiac magnetic resonance. Two methods have been investigated recently: (1) myocardial CT perfusion and (2) fractional flow reserve (FFR) computed from CT (FFRCT).
View Article and Find Full Text PDFCatheter Cardiovasc Interv
August 2014
Section of Interventional Cardiology, MedStar Heart Institute, MedStar Washington Hospital Center, Washington, DC.
Crit Care Med
July 2014
Surgical Critical Care Services, MedStar Washington Hospital Center, Washington, DC; MedStar Heart Institute and Advanced Heart Failure Service, MedStar Washington Hospital Center, Washington, DC, and Cardiac Transplantation, Children's National Medical Center, Washington, DC.